Description
This collection of transactions and supporting information was developed using our AI algorithm to curate similar royalty reports into a cohesive collection to support your licensing, transfer pricing or other transaction scenarios where documented royalty rates and/or deal terms are important.
Category: Technology Licenses
Created On: 2022-04-28
Record Count: 5
Primary Industries
- Medical
- Device
- Therapeutic
- Surgical
- Technical Know How
IPSCIO Report Record List
Below you will find the records curated into this collection. This summary includes the complete licensed property description so that you can review and determine if this collection covers the topics, technology or transaction type that is relevant for your needs. The full report will include all relevant deal data such as the royalty base, agreement date, term description, royalty rates and other deal terms. For reference, here is a sample of a full IPSCIO curated royalty rate report: Sample Report
IPSCIO Record ID: 4196
License Grant
The Licensee entered into an exclusive, subLicenseable, royalty bearing License with the Licensor, a University foundation, for the development and commercialization of the Licensor's technology.
License Property
This technology pertains to the Licensee's Oscillating Field Stimulator Device and the Oscillating Field Stimulator Device Plus, and a series of neurotrophic and other drugs to be utilized with the Oscillating Field Stimulator Device or on their own.
The existing platform includes a patented medical device known as an AndaraTM Oscillating Field Stimulator. The Device is being developed to regenerate spinal cord tissue and improve or restore tactile sensation and movement in those with quadriplegia and tetraplegia due to spinal cord injury.
Field of Use
The Device is designed to treat acute injuries and Devise Plus, which includes the use of neurotrophic growth factor, is being developed for long-term (chronic) spinal cord injuries.
IPSCIO Record ID: 275838
License Grant
The Foundation, nonprofit foundation of an University, grants, and Licensee accepts, an exclusive license to the Licensed Patents and Licensed IP to develop, make, have made, use, and sell Licensed Products on a royalty-bearing basis in the Field of Use in the Licensed Territory and for issuance of corresponding Sublicenses directly between Licensee and a Sublicensee.
License Property
Technology
Oscillating Field Stimulation (OFS)
Oscillating Field Stimulation and a Growth Factor
4-AP Derivatives
Hydralazine
Hydralazine + PEG
PEG for Vascular Leakage
Double Sucrose Gap Recording Apparatus
Coherent Anti-Stokes Raman Scattering
Licensed Patents shall mean
4,919,140 – Method and apparatus for regenerating nerves
OFS + Inosine Technology means the technology No 62139, US Patent Application No. 10/748,572 and /or PT Patent Application No. PCT/US2003/01480.
Field of Use
Field of Use shall mean human and veterinary therapeutics.
IPSCIO Record ID: 7008
License Grant
Licensor, a non-profit health care organization, hereby grants to Licensee the worldwide, sole exclusive License, including the right to grant subLicenses, under the Patent Rights and to practice the Licensed Processes.
License Property
This application generally relates to medical devices and more specifically relates to medical devices for use in the surgical treatment of hyperproliferative diseases affecting the spinal cord.
Field of Use
Field of Use shall mean treatment of Spinal cord injury.
IPSCIO Record ID: 88532
License Grant
The Licensor hereby grants to the Licensee, and the Swiss Licensee hereby accepts, a non-exclusive, royalty-bearing right and license under the Licensed IP to use, make, have made, sell, offer to sell, distribute and import Licensed Products in the Territory during the Term for applications within the Field of Use; provided, however, that upon the occurrence of a License Conversion Event, the portion of the non-exclusive license consisting of the non-exclusive, royalty-bearing license to sell, offer to sell, distribute and import Licensed Products in the Territory during the Term for applications within the Field of Use (the Non-Exclusive Distribution License) shall immediately, and without the need for any action on the part of either party, convert into an exclusive, royalty-bearing license to sell, offer to sell, distribute and import Licensed Products in the Territory during the Term for applications within the Field of Use (Exclusive Distribution License); provided, however, that the exclusivity of such Exclusive Distribution License shall be subject to, and shall not impact, any license rights previously granted in favor of Greatbatch pursuant to the Greatbatch License Agreement; provided, further, however, that if the Licensee fails to obtain FDA Approval for the Licensed Products within six (6) years after the License Conversion Date, the Exclusive Distribution License shall become convertible by the Licensor, at its sole discretion, back into a Non-Exclusive Distribution License. For the avoidance of doubt, during the Term, the non-exclusive, royalty-bearing license to use, make and have made Licensed Products in the Territory during the Term for applications within the Field of Use shall continuously remain a non-exclusive license. License Conversion Event means the first to occur of (i) receipt of a Conformité Européenne (CE) mark for the Licensed Products that permits sale of such Licensed Products within the European Economic Area for application within the Field of Use; (ii) receipt of FDA Approval or (iii) completion by the Licensee of a human clinical study demonstrating safety and efficacy required to obtain (A) a Conformité Européenne (CE) mark for the Licensed Products that permits sale of such Licensed Products within the European Economic Area for applications within the Field of Use, or (B) FDA Approval.
License Property
United States (U.S.) Licensed Patents
8,954,148 Key Fob controller for an implantable neurostimulator
8,483,836 Automated search to identify a location for electrical stimulation to treat a patient
8,515,545 Current steering neurostimulator device with unidirectional current sources
8,571,667 Active current control using the enclosure of an implanted pulse generator
8,738,153 Implantable lead with braided conductors
8,757,485 System and method for using clinician programmer and clinician programming data for inventory and manufacturing prediction and control
8,761,892 Active current control using the enclosure of an implanted pulse generator
8,761,897 Method and system of graphical representation of lead connector block and implantable pulse generators on a clinician programmer
8,781,592 Identifying an area for electrical stimulation to treat a patient
8,812,125 Systems and methods for the identification and association of medical devices
8,868,199 System and method of compressing medical maps for pulse generator or database storage
8,874,219 Arbitrary waveform generator and neural stimulation application
8,903,496 Clinician programming system and method
8,983,616 Method and system for associating patient records with pulse generators
8,996,115 Charge balancing for arbitrary waveform generator and neural stimulation application
8,996,117 Arbitrary waveform generator and neural stimulation application with scalable waveform feature
8,700,175 Devices and methods for visually indicating the alignment of a transcutaneous energy transfer device over an implanted medical device
9,002,466 Diversity antennas for neurostimulator programming devices
9,031,664 Current steering neurostimulator device with unidirectional current sources
9,031,666 Devices and methods for visually indicating the alignment of a transcutaneous energy transfer device over an implanted medical device
9,067,074 Automated search to identify a location for electrical stimulation to treat a patient
9,072,903 System and method of establishing a protocol for providing electrical stimulation with a stimulation system to treat a patient
9,098,610 Communication for implantable medical devices
9,101,767 Measuring load impedance with active stimulation pulses in an mplanted pulse generator
9,126,043 Patient handheld device for use with a spinal cord stimulation system
D663,035 Two-port implantable medical device
D665,086 Three-port implantable medical device
D665,087 Multi-port implantable medical device
D671,900 Pocket controller for implantable neurostimulator
D698,779 Clinician programmer for implantable neurostimulator
Field of Use
Field of Use means deep brain stimulation for movement disorders (i.e. Parkinson’s disease and/or essential tremor).
IPSCIO Record ID: 316774
License Grant
This agreement is an exclusive, worldwide license to the porcine tissue. Along with this license agreement, the Parties entered into a supply agreement, whereby Licensor would be the exclusive supplier to Licensee of the licensed porcine tissue.
License Property
This agreement is an exclusive, worldwide license to the porcine tissue for use in the Licensee’s Cardiac Patch and CanGaroo products, subject to certain co-exclusive rights retained by Licensor.
The SIS ECM biomaterial used in the medical device products are manufactured by Licensor. CanGaroo is soft and pliable and is designed to conform to the implantable device for easy handling and implantation. The SIS ECM is designed to mitigate the biologic foreign body response that normally occurs around the electronic device.
The CanGaroo envelope is constructed from perforated, multi-laminate sheets of decellularized, non-crosslinked, lyophilized small intestine submucosa (SIS) extracellular matrix (ECM), derived from porcine small intestinal submucosa, a natural biomaterial, which is rich in natural growth factors, structural proteins and collagens.
Field of Use
Specifically, the field of use is with neuromodulation devices in addition to cardiovascular devices; for use in the Licensee’s Cardiac Patch and CanGaroo products.
CanGaroo was designed to mitigate complications deriving from implantable electronic devices and the shortcomings of synthetic envelopes. We believe that CanGaroo is the only biological product that forms a natural, systemically vascularized pocket that conforms to and securely holds implantable electronic devices. CanGaroo is cleared for use with pacemaker pulse generators, defibrillators and other cardiac implantable electronic devices as well as vagus nerve stimulators, spinal cord neuromodulators, deep brain stimulators and sacral nerve stimulators.
Disclaimer: The information gathered from RoyaltySource® database was sourced from the U.S. Securities and Exchange Commission EDGAR Filings and other public records. While we believe the sources to be reliable, this does not guarantee the accuracy or completeness of the information provided. Further, the information is supplied as general guidance and is not intended to represent or be a substitute for a detailed analysis or professional judgment. This information is for private use only and may not be resold or reproduced without permission.
